| Name | Title | Contact Details |
|---|
Chase Brexton is an equal opportunity employer committed to providing all employees, patients, applicants, and visitors with a safe and supportive environment. Everyone is welcomed and accepted, regardless of race, gender, nation of origin, sexual orientation, gender identity, marital status, religion, socio-economic status, veteran status, or disability. Minority applicants are strongly encouraged to apply. Part of our vision at Chase Brexton is to empower our staff and foster a culture that promotes staff development and satisfaction. We believe our staff is key to achieving our mission to provide compassionate, quality health care that honors diversity, inspires wellness, and improves our communities. Our work is not possible without a strong, devoted, and talented staff. Chase Brexton offers a comprehensive benefits package including medical and dental insurance, vacation, sick leave, paid holidays, long- and short-term disability, life insurance, tuition reimbursement, an Employee Assistance Program, and a tax-free retirement plan with company matching contributions. All in a professional, supportive environment.
The Integrated Health and Social Services University Network for West-Central Montreal (CIUSSS West-Central Montreal) is one of the largest health and social services network in the Montreal area, regrouping over 20 establishments in the west end of Montreal and serving a population of nearly 345,000. We are making the difference, one person at a time. CIUSSS West-Central Montreal`s services and programs span the continuum of healthcare, from hospital to community integrated services to residential care. Our 9,000 employees, including 900 doctors, are guided by values of compassion, integrity and commitment to the quality of care. We are proud of our official bilingual status and the culturally rich identities of our sites. On top of clinical activities, research and teaching play an integral part in the CIUSSS West-Central Montreal network.
Indiana Regional Medical Center is the only regional hospital that offers a dedicated Center for Wound Healing to help heal chronic wounds as well as Hyperbaric Oxygen Therapy for non-healing wounds.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Kimball International consists of furniture brands: Kimball, National, Interwoven, Etc, Poppin, DStyle and Kimball Hospitality.